logo image

ANAGRELIDE

ANAGRELIDE

Capsules

ANAGRELIDE 0.5 MG CAPSULES
The mechanism by which anagrelide reduces blood platelet count is still under investigation. Studies in patients support a hypothesis of dose-related reduction in platelet production resulting from a decrease in megakaryocyte hypermaturation.
Agrylin (anagrelide) Capsules - 0.5 mg .
The recommended starting dosage of AGRYLIN® for adult patients is 0.5 mg qid or 1 mg bid (2 capsules of 0.5 mg twice a day), which should be maintained for at least one week. Starting doses in pediatric patients have ranged from 0.5 mg per day to 0.5 mg qid.
AGRYLIN® Capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.

Contact Us

Established in New Delhi, India in 2020, ImpoMed Healthcare has grown over the years from a new start up to one of the Most Preferred Company for Facilitation of the Imported Drugs-Only USFDA/European FDA Approved.

Quick Links

Diseases

Corporate Office